首页> 外文期刊>Cell >Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis
【24h】

Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis

机译:PKCζ在肿瘤发生中控制营养胁迫诱导的代谢重编程。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor cells have high-energetic and anabolic needs and are known to adapt their metabolism to be able to survive and keep proliferating under conditions of nutrient stress. We show that PKCζ deficiency promotes the plasticity necessary for cancer cells to reprogram their metabolism to utilize glutamine through the serine biosynthetic pathway in the absence of glucose. PKCζ represses the expression of two key enzymes of the pathway, PHGDH and PSAT1, and phosphorylates PHGDH at key residues to inhibit its enzymatic activity. Interestingly, the loss of PKCζ in mice results in enhanced intestinal tumorigenesis and increased levels of these two metabolic enzymes, whereas patients with low levels of PKCζ have a poor prognosis. Furthermore, PKCζ and caspase-3 activities are correlated with PHGDH levels in human intestinal tumors. Taken together, this demonstrates that PKCζ is a critical metabolic tumor suppressor in mouse and human cancer.
机译:肿瘤细胞具有高能量和合成代谢的需求,并且已知能够调节其新陈代谢以在营养胁迫的条件下存活并保持增殖。我们表明,PKCζ缺乏促进癌细胞重新编程其代谢以在没有葡萄糖的情况下通过丝氨酸生物合成途径利用谷氨酰胺所必需的可塑性。 PKCζ抑制该途径的两种关键酶PHGDH和PSAT1的表达,并在关键残基处磷酸化PHGDH以抑制其酶促活性。有趣的是,小鼠体内PKCζ的丧失导致肠道肿瘤发生的增强和这两种代谢酶的水平升高,而PKCζ水平低的患者预后较差。此外,PKCζ和caspase-3活性与人类肠道肿瘤中的PHGDH水平相关。两者合计,这表明PKCζ是小鼠和人类癌症中的关键代谢肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号